Biomerieux SA
BMXMF · NYSE
$100.57+$5.57 (+5.86%)TodayMarket closed ·
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 9.8% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $2.02 | $1.99 | −1.5% |
| Q4 FY25 | $2.08 | $2.30 | +10.5% |
| Q2 FY25 | $2.24 | $1.35 | −39.8% |
| Q4 FY24 | $2.17 | $2.04 | −6.1% |
| Q2 FY24 | $1.77 | $1.82 | +3.0% |
| Q4 FY22 | $2.18 | $1.89 | −13.4% |
| Q2 FY22 | $2.24 | $1.93 | −13.9% |
| Q4 FY21 | $2.37 | $2.75 | +15.9% |
Earnings calls
- BIM.PA - Earnings call Q2 2026
- bioMérieux S.A., Q1 2026 Sales/ Trading Statement Call, Apr 23, 2026
- BIM.PA - Earnings call Q4 2025
- Analyst/Investor Day - bioMérieux S.A.
- BIM.PA - Earnings call Q2 2025
- bioMérieux S.A., Q1 2025 Sales/ Trading Statement Call, Apr 17, 2025
- 2024 Earnings Call
- 43rd Annual J.P. Morgan Healthcare Conference 2025
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.